Navigation Links
Genasense(R) Triple Combination Therapy in Advanced Melanoma Presented at Chemotherapy Foundation Symposium
Date:11/8/2007

Genasense Plus Temodar(R) and Abraxane(R) Show Promising Early Clinical

Activity

BERKELEY HEIGHTS, N.J., Nov. 8 /PRNewswire-FirstCall/ -- Genta Incorporated (Nasdaq: GNTA) today announced the presentation of clinical data using the Company's lead oncology drug, Genasense(R) (oblimersen sodium) Injection in combination with Abraxane(R) (paclitaxel protein-bound particles for injectable suspension) (albumin-bound; Abraxis BioScience, Inc.) and Temodar(R) (temozolomide; Schering Plough, Inc.) in patients with advanced metastatic melanoma. The study represents the rapid translation of preclinical results that demonstrated marked anticancer synergy with this drug combination. The results will be presented by Dr. Anna C. Pavlick, New York University School of Medicine, at the Chemotherapy Foundation Symposium XXV, entitled "Innovative Cancer Therapy for Tomorrow", at the Marriott Hotel, New York, NY on November 9, 2007.

To date, 8 patients have been accrued to this trial. Of the first 7 evaluable patients, 5 patients have demonstrated clinical benefit, including 3 partial responses that occurred after the first treatment cycle, which have lasted for 40, 24 and 16 weeks, respectively. Two other patients have maintained stable disease lasting for a minimum of 24 weeks. Two patients had progressive disease, and one patient is too early to evaluate. There have been no episodes of Grade 4 (i.e., life-threatening) side-effects. Four patients experienced Grade 3 leukopenia (i.e., reduction in white blood cell count), and 1 patient had Grade 3 thrombocytopenia (i.e., reduction in platelet count).

"Our goal with this trial is to evaluate the synergy of Genasense with drugs other t
'/>"/>

SOURCE Genta Incorporated
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Genta Announces Presentation of New Clinical and Preclinical Data on Genasense(R) at AACR-NCI-EORTC Targets Conference
2. Genta Completes Appeal of FDA Decision for Genasense(R) in CLL
3. New Phase III Data Demonstrate Oxycodone / Naloxone Combination Tablet Reduces Opioid-Induced Bowel Dysfunction in Patients With Chronic Severe Pain
4. Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
5. DAIICHI SANKYO EUROPE is Applying for Approval of its New Combination Product of Olmesartan and Amlodipin
6. Oncolytics Biotech Inc. Announces Approval for U.K. Clinical Trial Investigating REOLYSIN(R) in Combination with Cyclophosphamide
7. Oncolytics Biotech Inc. Collaborators to Present Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
8. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
9. Medinet Licenses MaxCyte Cell Loading Technology for Cancer Immunotherapy in Japan
10. Exelixis Reports Encouraging Interim Data From a Phase 2 Trial of XL647 as First-Line Therapy for Non-Small Cell Lung Cancer
11. Study Supports Use of GlycoMark Blood Test to Evaluate Therapy in Children with Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... Cayenne Medical, Inc., a privately ... soft tissue reconstruction segment, announced the worldwide launch ... involving the shoulder and extremities. The SureLock System ... deployment method. The unique delivery eliminates manual tensioning ... or anchor displacement (also commonly know as anchor ...
(Date:7/10/2014)... Boston, Mass. (PRWEB) July 10, 2014 ... , today announced that Alan Swahn, a former vice ... Terascala’s executive team as vice president of marketing. Terascala’s ... from Dell and NetApp create the highest performance and ... has been appointed to guide Terascala’s channel expansion and ...
(Date:7/10/2014)... Calabasas, CA (PRWEB) July 10, 2014 ... academic institutions and professional associations, addressed the challenges of ... & Medical Device Industries” through strategic sourcing. Describing the ... ) with the Supply Chain Management Institute ( SCMI) ... the event on June 24 at the Kroc Institute ...
(Date:7/10/2014)... -- Research and Markets ( http://www.researchandmarkets.com/research/s3bqj2/photonic ) has ... Integrated Circuit (Monolithic Integration, Hybrid Integration, Module Integration) ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... traces its roots in the latter half of ... went unexplored and unfulfilled for several decades owing ...
Breaking Biology Technology:Cayenne Medical Launches SureLock™ All-Suture Anchor System for Shoulder and Extremity Surgery 2Cayenne Medical Launches SureLock™ All-Suture Anchor System for Shoulder and Extremity Surgery 3Terascala Expands Executive Team 2Terascala Expands Executive Team 3Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 2Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 3Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 4International Photonic Integrated Circuit (Monolithic Integration, Hybrid Integration, Module Integration) Market - Forecasts to 2019 2
... Kit , , ... MicroRNAs (miRNAs) are extremely small RNA , ... of RNA in a sample (10 g total RNA contains ... their small size and low abundance, miRNAs can be extremely , ...
... Jaclyn Shingara, Kerri Keiger, Ila , ... R&D Division, , ... MicroRNAs (miRNAs) are small, , ... animals, that regulate the expression of genes by binding to , ...
... , Uncover Critical Regulatory Pathways by Analyzing a Complete Set of Human and Mouse ... The miRNA gene family contains ... yet their presence and , ... (see <A , ...
Cached Biology Technology:Highly Sensitive microRNA Array Performance 2Highly Sensitive microRNA Array Performance 3Highly Sensitive microRNA Array Performance 4Highly Sensitive microRNA Array Performance 5Highly Sensitive microRNA Array Performance 6Highly Sensitive microRNA Array Performance 7Highly Sensitive microRNA Array Performance 8MicroRNA Profiling by Array Analysis Reveals Critical BioMarkers 2MicroRNA Profiling by Array Analysis Reveals Critical BioMarkers 3MicroRNA Profiling by Array Analysis Reveals Critical BioMarkers 4MicroRNA Profiling by Array Analysis Reveals Critical BioMarkers 5MicroRNA Profiling by Array Analysis Reveals Critical BioMarkers 6MicroRNA Profiling by Array Analysis Reveals Critical BioMarkers 7MicroRNA Profiling by Array Analysis Reveals Critical BioMarkers 8MicroRNA Profiling by Array Analysis Reveals Critical BioMarkers 9MicroRNA Profiling by Array Analysis Reveals Critical BioMarkers 10MicroRNA Profiling by Array Analysis Reveals Critical BioMarkers 11MicroRNA Profiling by Array Analysis Reveals Critical BioMarkers 12MicroRNA Profiling by Array Analysis Reveals Critical BioMarkers 13Novel MicroRNA Array Technology for Sensitive miRNA Profiling 2Novel MicroRNA Array Technology for Sensitive miRNA Profiling 3
(Date:7/10/2014)... N.Y. , July 2, 2014 It ... (ABD) to announce the appointment of the world-renowned Thoracic ... Board of Directors. Dr. Ginsburg, with over ... facilities: NY Presbyterian Hospital and Good Samaritan Regional Medical ... Pacemaker since the late 1980,s and is considered an ...
(Date:7/10/2014)... 2014 According to the new ... And Area), Material (Optical Prism, Pizeoelectric, Capacitive, and Adhesives), ... Banking & Finance), and Geography - Global Trends & ... global Fingerprint Sensors Market is projected to cross $14.35 ... 16.8% from 2014 to 2020. Browse more ...
(Date:7/10/2014)... 7, 2014 Fingerprint Cards, (FPC,s) new ... win (DW). A Chinese Top 5 smartphone OEM has selected ... mass production in October 2014.   FPC is ... smartphone OEM, which has a planned date for the start ... volume for this phone of 3 million units. The Chinese ...
Breaking Biology News(10 mins):Avery Biomedical Devices, Inc. announces the appointment of Mark E Ginsburg, M.D. to its Board of Directors 2Fingerprint Sensors Market worth $14.35 Billion by 2020 2Fingerprint Sensors Market worth $14.35 Billion by 2020 3FPC Wins DW for 1021 Touch Sensor for Flagship Smartphone from Chinese Top 5 Smartphone OEM 2
... 2010 The American Society for Biochemistry and Molecular ... the nonprofit,s annual awards. Another winner was announced earlier ... the society,s annual meeting April 9-13 in Washington, D.C., ... Hughes Medical Institute investigator Axel T. Brunger won the ...
... Lysis of Thromboembolic Stroke (CLOTS)an intensive five-day course ... 24-28 in Dallas, Texasprovides interventional radiologists, neurointerventionalists, vascular ... to review, observe and discuss all aspects of ... third-leading cause of death in the United States, ...
... scientific discoveries these days. Two middle school students from ... the first glimpse of the innermost structure of a ... anti-cancer agents so that those substances do their job. ... . The student co-authors of the study are from ...
Cached Biology News:American Society for Biochemistry and Molecular Biology honors 11 outstanding scientists 2American Society for Biochemistry and Molecular Biology honors 11 outstanding scientists 3American Society for Biochemistry and Molecular Biology honors 11 outstanding scientists 4Explore stroke care with Society of Interventional Radiology's CLOTS 2
DNA Repair Sampler Kit 10g each...
Protein Tyrosine Phosphatase Sampler Kit 10g each...
SH3 Proteins II Sampler Kit 10g each...
... Solid phase reagent for ... Easy & unique water ... with detergents and chaotropes; ... recover non-envelop viruses while ...
Biology Products: